An integrated clinicoradiological staging system for pulmonary sarcoidosis: A case-cohort study

The Lancet Respiratory Medicine

Volumn 2, Issue 2, 2014, Pages 123-130

  Walsh, Simon LF ^a   Wells, Athol U ^a   Sverzellati, Nicola ^b   Keir, Gregory J ^a   Calandriello, Lucio ^c   Antoniou, Katerina M ^d   Copley, Susan J ^e   Devaraj, Anand ^f   Maher, Toby M ^a   Renzoni, Elizabetta ^a   Nicholson, Andrew G ^a   Hansell, David M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PARMA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF CRETE   (Greece)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 84895076197     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70276-5     Document Type: Article

References (41)

1. Iannuzzi MC, Rybicki BA, Teirstein AS Sarcoidosis. N Engl J Med 2007, 357:2153-2165.
2. Rybicki BA, Maliarik MJ, Major M, Popovich J, Iannuzzi MC Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect 1998, 13:166-173.
3. Perry A, Vuitch F Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995, 119:167-172.
4. Chappell AG, Cheung WY, Hutchings HA Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis 2000, 17:167-173.
5. Baughman RP, Engel PJ, Taylor L, Lower EE Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest 2010, 138:1078-1085.
6. Grutters JC, van den Bosch JMM Sarcoidosis. Eur Respir Monograph 2009, 46:126-154.
7. Drent M, De Vries J, Lenters M, et al. Sarcoidosis: assessment of disease severity using HRCT. Eur Radiol 2003, 13:2462-2471.
8. Akira M, Kozuka T, Inoue Y, Sakatani M Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis. Chest 2005, 127:185-191.
9. Morgenthau AS, Iannuzzi MC Recent advances in sarcoidosis. Chest 2011, 139:174-182.
10. Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 1994, 191:675-680.
11. Clement DS, Postma G, Rothova A, Grutters JC, Prokop M, de Jong PA Intraocular sarcoidosis: association of clinical characteristics of uveitis with positive chest high-resolution computed tomography findings. Br J Ophthalmol 2010, 94:219-222.
12. Baughman RP, Winget DB, Bowen EH, Lower EE Predicting respiratory failure in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 1997, 14:154-158.
13. Vestbo J, Viskum K Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis. Sarcoidosis 1994, 11:123-125.
14. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999, 160:736-755. Statement on sarcoidosis.
15. Reich JM Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy. Chest 2002, 121:32-39.
16. Handa T, Nagai S, Miki S, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006, 129:1246-1252.
17. Shorr AF, Helman DL, Davies DB, Nathan SD Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005, 25:783-788.
18. Sulica R, Teirstein AS, Kakarla S, Nemani N, Behnegar A, Padilla ML Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest 2005, 128:1483-1489.
19. Arcasoy SM, Christie JD, Pochettino A, et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001, 120:873-880.
20. Baughman RP, Engel PJ, Meyer CA, Barrett AB, Lower EE Pulmonary hypertension in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006, 23:108-116.
21. Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003, 167:962-969.
22. Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007, 131:657-663.
23. Quanjer PH Standardised lung function testing. Clin Respir Physiol 1983, 19:1-95.
24. Brennan P, Silman A Statistical methods for assessing observer variability in clinical measures. BMJ 1992, 304:1491-1494.
25. Shigemitsu H, Nagai S, Sharma OP Pulmonary hypertension and granulomatous vasculitis in sarcoidosis. Current opinion in pulmonary medicine. Curr Opin Pulm Med 2007, 13:434-438.
26. Rizzato G, Pezzano A, Sala G, et al. Right heart impairment in sarcoidosis: haemodynamic and echocardiographic study. Eur J Respir Dis 1983, 64:121-128.
27. Gluskowski J, Hawrylkiewicz I, Zych D, Zielinski J Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis. Eur Respir J 1990, 3:403-407.
28. Gluskowski J, Hawrylkiewicz I, Zych D, Wojtczak A, Zielinski J Pulmonary haemodynamics at rest and during exercise in patients with sarcoidosis. Respiration 1984, 46:26-32.
29. Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006, 61:68-74.
30. Haimovici JB, Trotman-Dickenson B, Halpern EF, et al. Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Massachusetts General Hospital Lung Transplantation Program. Acad Radiol 1997, 4:327-334.
31. Kuriyama K, Gamsu G, Stern RG, Cann CE, Herfkens RJ, Brundage BH CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Invest Radiol 1984, 19:16-22.
32. Ng CS, Wells AU, Padley SP A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999, 14:270-278.
33. Devaraj A, Wells AU, Meister MG, Corte TJ, Hansell DM The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology 2008, 249:1042-1049.
34. Devaraj A, Wells AU, Meister MG, Corte TJ, Wort SJ, Hansell DM Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. Radiology 2010, 254:609-616.
35. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009, 53:1573-1619.
36. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986, 133:97-103.
37. King TE, Tooze JA, Schwarz MI, Brown KR, Cherniack RM Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001, 164:1171-1181.
38. Goh NS, Desai SR, Veeraraghavan S, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008, 177:1248-1254.
39. Baughman RP, Iannuzzi MC Diagnosis of sarcoidosis: when is a peek good enough?. Chest 2000, 117:931-932.
40. Baughman RP, Culver DA, Judson MA A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 2011, 183:573-581.
41. Raghu G, Collard HR, Anstrom KJ, et al. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med 2012, 185:1044-1048.